Zymeworks BC Insider Trades

ZYME

Track insider trading activity from Zymeworks BC executives and directors. See which insiders are buying and selling ZYME stock.

Trades Last 12 Months

ZYME Price

All Insider Trades for Zymeworks BC

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Schayowitz Adam Evp, Head Of R&d
Holding Value $1.07M 37,037 shares
Last Trade
Oct 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$955k 37,037 shares
$25.79
$28.99
Hollywood Mark EVP & Chief Operating Officer
Holding Value $3.88M 133,852 shares
Last Trade
Jul 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.8k 939 shares
$25.33
$28.99
Platshon Scott Evp, Chief Business Officer
Holding Value $2.2M 76,000 shares
Last Trade
Apr 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.28M 193,000 shares
$27.35
$28.99
Stafford Kristin Evp, Chief Financial Officer
Holding Value $5.16M 178,000 shares
Last Trade
Apr 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.97M 347,000 shares
$25.84
$28.99
Mekan Sabeen SVP & Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 01, 2026 Sale
$6.13M 272,000 shares
$22.53
$28.99
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Galbraith Kenneth Chair & CEO
Holding Value $6.44M 222,000 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5M 582,000 shares
$23.16
$28.99
Moore Paul Andrew Chief Scientific Officer
Holding Value $1.68M 58,057 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$409k 17,666 shares
$23.16
$28.99
Smith Jeffrey T L EVP & Chief Medical Officer
Holding Value $1.04M 36,018 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$409k 17,666 shares
$23.16
$28.99
Campoy Carlos Director
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Cherry Brian N Director
Holding Value $667k 23,000 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 38,400 shares
$26.79
$28.99
Landry Robert E Director
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Mahony Susan Director
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Neu Kelvin Director
Holding Value $333k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$28.99
Patterson Leone D Evp, Chief Bus & Fin Officer
Holding Value $13.3k 459 shares
Last Trade
Jan 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1k 459 shares
$24.18
$28.99
Ecor1 Capital, Llc 10% owner
Holding Value $0 0 shares
Last Trade
Jun 26, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$62.9M 5,086,521 shares
$12.37
$28.99
Cox Troy Director
Holding Value $899k 31,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 31,000 shares
$13.06
$28.99
Holding Value $899k 31,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 31,000 shares
$13.06
$28.99
Gallagher Neil Director
Holding Value $899k 31,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 31,000 shares
$13.06
$28.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up